Following the death of a patient with blastic plasmacytoid dendritic cell neoplasm (BPDCN), the FDA put a hold...
Up To Date
Latest News
Dutch venture capital company BioGeneration Ventures (BGV) has closed its third fund, BGV III, at €82m...
Belgian nanobody producer Ablynx closes an initial public offering of American Depositary Shares at Nasdaq...
The world’s largest event for pharma professionals, CPHI worldwide, will see an expansion to the...
US biotech company Regeneron Pharmaceuticals revealed plans to create some 300 new jobs in Ireland's Limerick...
Portuguese biotech company Immunethep has convinced the Bill & Melinda Gates Foundation to hand out a grant...
Share
